Eli Lilly will seek regulatory approval for retatrutide, a powerful weight loss drug that a new study shows helped people ...

In two new phase 3 clinical trials, the experimental GLP-1 drug also improved blood sugar, heart health metrics, and ...

Should you weigh yourself every day while trying to lose weight? A health educator explains why tracking your weight daily ...

As the world's first natural GLP-1 option clinically proven to facilitate weight loss, Calocurb opens new doors for individuals on a weight management journey. Rooted in overall wellness, science, and ...

Novo says that Lilly’s advertising campaigns rely on outdated weight-loss comparisons with lower doses of Novo’s own obesity ...

Eli Lilly is preparing application materials for its next-generation weight-loss drug, retatrutide, following data from two ...

Eli Lilly said Thursday it plans to file for regulatory approval of its next-generation weight loss drug retatrutide in the ...

Novo Nordisk claims Eli Lilly compared peak doses of Zepbound against outdated, lower doses of Wegovy to advertise a 50-pound weight loss versus 33 pounds ...

Individuals with overweight or obesity can have a higher risk of heart disease despite appearing to be healthy, new research ...

Weight gains and fluctuations are a normal part of everyone’s lives. But for football players and other athletes, this change ...

Losing about 80 minutes of sleep each night for six weeks led participants to gain an average of one pound.People also became ...

For many people taking a glucagon-like peptide-1 (GLP-1) receptor agonist, losing stubborn weight linked to various health issues can feel life-changing. But when you start seeing more clumps of ...